TRUE Private Wealth Advisors’s NanoViricides NNVC Stock Holding History

TRUE Private Wealth Advisors’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$13K	Hold	10,000	–	–	﹤0.01%	286
2026 Q2	$13.8K	Hold	10,000	–	–	﹤0.01%	282
2026 Q1	$9.12K	Hold	10,000	–	–	﹤0.01%	266
2025 Q4	$11.3K	Hold	10,000	–	–	﹤0.01%	266
2025 Q3	$14.3K	Buy	+10,000	New	+$15K	﹤0.01%	263

Other funds holding NNVC

Miller Financial Services Marshall, Michigan $132M AUM 10.64% 1-Year Est. Return

Foster Victor Wealth Advisors Greenville, South Carolina $2.02B AUM 20.94% 1-Year Est. Return

NBC Securities Birmingham, Alabama $1.47B AUM 20.38% 1-Year Est. Return

Newbridge Financial Services Group Boca Raton, Florida $868M AUM 42.47% 1-Year Est. Return

Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

TRUE Private Wealth Advisors's NNVC Position: Q3 2026 in Review

TRUE Private Wealth Advisors held its NanoViricides (NNVC) position steady in Q3 2026 at 10,000 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #286.

TRUE Private Wealth Advisors first reported a position in NNVC in Q3 2025 and has held it in 5 quarters since. The position peaked at $14.3K in Q3 2025. 9 funds tracked by Wall St. Rank hold NNVC as of Q3 2026.

TRUE Private Wealth Advisors held 10,000 shares of NanoViricides worth $13K as of Q3 2026.
TRUE Private Wealth Advisors left its NanoViricides share count unchanged in Q3 2026.
NanoViricides made up ﹤0.01% of TRUE Private Wealth Advisors's portfolio in Q3 2026, its #286 holding.
TRUE Private Wealth Advisors first reported a position in NanoViricides in Q3 2025 and has held it in 5 quarters since.
TRUE Private Wealth Advisors's NanoViricides position peaked at $14.3K in Q3 2025.
9 funds tracked by Wall St. Rank held NanoViricides as of Q3 2026.

Based on TRUE Private Wealth Advisors's 13F filing for Q3 2026, filed 19 Oct 2026.